A Study Evaluating the Long-Term Safety of Elexacaftor Combination Therapy

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2020
This study evaluate the long-term safety and tolerability of elexacaftor (ELX)/tezacaftor (TEZ)/ ivacaftor (IVA) triple combination (TC) in participants with cystic fibrosis (CF) who are homozygous for F508del.
Epistemonikos ID: 1ed6b55e1cf3f5dae48e930c445b90aa3574350c
First added on: May 07, 2024